Diagnostic Radiopharmaceuticals Market Report

Global Diagnostic Radiopharmaceuticals Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：172
  • REPORT CODE：GMM874847
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Diagnostic Radiopharmaceuticals market report explains the definition, types, applications, major countries, and major players of the Diagnostic Radiopharmaceuticals market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Bracco Imaging

    • Jubilant Pharma

    • Bayer

    • GE Healthcare

    • Eli Lilly

    • Dongcheng

    • Novartis

    • SIEMENS

    • Curium Pharmaceuticals

    • Navidea

    • China Isotope & Radiation

    • Nordion

    • Triad Isotopes

    • Lantheus

    By Type:

    • Tc-99m

    • F-18

    • Other

    By End-User:

    • Oncology

    • Cardiology

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Diagnostic Radiopharmaceuticals Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Diagnostic Radiopharmaceuticals Outlook to 2028- Original Forecasts

    • 2.2 Diagnostic Radiopharmaceuticals Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Diagnostic Radiopharmaceuticals Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Diagnostic Radiopharmaceuticals Market- Recent Developments

    • 6.1 Diagnostic Radiopharmaceuticals Market News and Developments

    • 6.2 Diagnostic Radiopharmaceuticals Market Deals Landscape

    7 Diagnostic Radiopharmaceuticals Raw Materials and Cost Structure Analysis

    • 7.1 Diagnostic Radiopharmaceuticals Key Raw Materials

    • 7.2 Diagnostic Radiopharmaceuticals Price Trend of Key Raw Materials

    • 7.3 Diagnostic Radiopharmaceuticals Key Suppliers of Raw Materials

    • 7.4 Diagnostic Radiopharmaceuticals Market Concentration Rate of Raw Materials

    • 7.5 Diagnostic Radiopharmaceuticals Cost Structure Analysis

      • 7.5.1 Diagnostic Radiopharmaceuticals Raw Materials Analysis

      • 7.5.2 Diagnostic Radiopharmaceuticals Labor Cost Analysis

      • 7.5.3 Diagnostic Radiopharmaceuticals Manufacturing Expenses Analysis

    8 Global Diagnostic Radiopharmaceuticals Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Diagnostic Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Diagnostic Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)

    9 Global Diagnostic Radiopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global Diagnostic Radiopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Tc-99m Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global F-18 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Diagnostic Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Diagnostic Radiopharmaceuticals Market Analysis and Outlook till 2022

    • 10.1 Global Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.2.2 Canada Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.2.3 Mexico Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.2 UK Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.3 Spain Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.4 Belgium Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.5 France Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.6 Italy Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.7 Denmark Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.8 Finland Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.9 Norway Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.10 Sweden Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.11 Poland Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.12 Russia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.3.13 Turkey Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.2 Japan Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.3 India Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.4 South Korea Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.5 Pakistan Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.6 Bangladesh Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.7 Indonesia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.8 Thailand Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.9 Singapore Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.10 Malaysia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.11 Philippines Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.4.12 Vietnam Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.2 Colombia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.3 Chile Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.4 Argentina Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.5 Venezuela Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.6 Peru Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.7 Puerto Rico Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.5.8 Ecuador Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.2 Kuwait Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.3 Oman Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.4 Qatar Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.2 South Africa Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.3 Egypt Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.7.4 Algeria Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Diagnostic Radiopharmaceuticals Consumption (2017-2022)

      • 10.8.2 New Zealand Diagnostic Radiopharmaceuticals Consumption (2017-2022)

    11 Global Diagnostic Radiopharmaceuticals Competitive Analysis

    • 11.1 Bracco Imaging

      • 11.1.1 Bracco Imaging Company Details

      • 11.1.2 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Bracco Imaging Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.1.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Jubilant Pharma

      • 11.2.1 Jubilant Pharma Company Details

      • 11.2.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.2.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bayer

      • 11.3.1 Bayer Company Details

      • 11.3.2 Bayer Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bayer Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.3.4 Bayer Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 GE Healthcare

      • 11.4.1 GE Healthcare Company Details

      • 11.4.2 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 GE Healthcare Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.4.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Eli Lilly

      • 11.5.1 Eli Lilly Company Details

      • 11.5.2 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Eli Lilly Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.5.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Dongcheng

      • 11.6.1 Dongcheng Company Details

      • 11.6.2 Dongcheng Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Dongcheng Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.6.4 Dongcheng Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Novartis

      • 11.7.1 Novartis Company Details

      • 11.7.2 Novartis Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Novartis Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.7.4 Novartis Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 SIEMENS

      • 11.8.1 SIEMENS Company Details

      • 11.8.2 SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 SIEMENS Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.8.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Curium Pharmaceuticals

      • 11.9.1 Curium Pharmaceuticals Company Details

      • 11.9.2 Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.9.4 Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Navidea

      • 11.10.1 Navidea Company Details

      • 11.10.2 Navidea Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Navidea Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.10.4 Navidea Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 China Isotope & Radiation

      • 11.11.1 China Isotope & Radiation Company Details

      • 11.11.2 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.11.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Nordion

      • 11.12.1 Nordion Company Details

      • 11.12.2 Nordion Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Nordion Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.12.4 Nordion Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Triad Isotopes

      • 11.13.1 Triad Isotopes Company Details

      • 11.13.2 Triad Isotopes Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Triad Isotopes Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.13.4 Triad Isotopes Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Lantheus

      • 11.14.1 Lantheus Company Details

      • 11.14.2 Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Lantheus Diagnostic Radiopharmaceuticals Main Business and Markets Served

      • 11.14.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    12 Global Diagnostic Radiopharmaceuticals Market Outlook by Types and Applications to 2028

    • 12.1 Global Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global F-18 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Diagnostic Radiopharmaceuticals Market Analysis and Outlook to 2028

    • 13.1 Global Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.2.2 Canada Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.2 UK Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.3 Spain Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.5 France Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.6 Italy Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.8 Finland Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.9 Norway Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.11 Poland Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.12 Russia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.2 Japan Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.3 India Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.3 Chile Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.6 Peru Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.3 Oman Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Diagnostic Radiopharmaceuticals Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Diagnostic Radiopharmaceuticals

    • Figure of Diagnostic Radiopharmaceuticals Picture

    • Table Global Diagnostic Radiopharmaceuticals Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Diagnostic Radiopharmaceuticals Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Tc-99m Consumption and Growth Rate (2017-2022)

    • Figure Global F-18 Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Table North America Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Canada Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Mexico Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Germany Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure UK Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Spain Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Belgium Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure France Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Italy Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Denmark Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Finland Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Norway Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Sweden Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Poland Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Russia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Turkey Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table APAC Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure China Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Thailand Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Singapore Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Philippines Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table South America Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Brazil Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Colombia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Chile Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Argentina Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Peru Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table GCC Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Bahrain Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Oman Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Qatar Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Africa Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Nigeria Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Africa Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Egypt Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Algeria Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Oceania Diagnostic Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure Australia Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Diagnostic Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Bracco Imaging Company Details

    • Table Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Jubilant Pharma Company Details

    • Table Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharma Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Bayer Company Details

    • Table Bayer Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Bayer Diagnostic Radiopharmaceuticals Product Portfolio

    • Table GE Healthcare Company Details

    • Table GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Dongcheng Company Details

    • Table Dongcheng Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongcheng Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Dongcheng Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Novartis Diagnostic Radiopharmaceuticals Product Portfolio

    • Table SIEMENS Company Details

    • Table SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table SIEMENS Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Curium Pharmaceuticals Company Details

    • Table Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Curium Pharmaceuticals Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Navidea Company Details

    • Table Navidea Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Navidea Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Navidea Diagnostic Radiopharmaceuticals Product Portfolio

    • Table China Isotope & Radiation Company Details

    • Table China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table China Isotope & Radiation Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Nordion Company Details

    • Table Nordion Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Nordion Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Triad Isotopes Company Details

    • Table Triad Isotopes Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Triad Isotopes Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Triad Isotopes Diagnostic Radiopharmaceuticals Product Portfolio

    • Table Lantheus Company Details

    • Table Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Diagnostic Radiopharmaceuticals Main Business and Markets Served

    • Table Lantheus Diagnostic Radiopharmaceuticals Product Portfolio

    • Figure Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Table North America Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Germany Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure China Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Brazil Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Diagnostic Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure Australia Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Diagnostic Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US